Dysmenorrhea treatment market

Page 1

Dysmenorrhea Treatment Market Medical Devices Pipeline Assessment, 2017 - Pipeline Products by Stage of Development SUMMARY Market Synopsis of Middle East and Africa Dysmenorrhea Treatment Market: Global Forecast till 2023 Market Scenario: Dysmenorrhea is a medical term for painful menstruation. Many women suffer from pain in lower abdomen during menstruation. This is due to low hemoglobin levels in women’s and lack of nutritious diet taken by women. Women nowadays have to cope up with both physical and mental stress due to personal issues and other work related problems. Most of them consult a physician for various reproductive disorders. The demand for the treatment of dysmenorrhea is increasing due to increasing reproductive disorders in women, irregular menstrual cycle, increase in lifestyle disorders and addiction to smoking deteriorating their physical and mental health. Lack of awareness about the treatment regarding various reproductive disorders and use of medications for their treatment also contribute for the growth of this market. Women in developed countries face many health issues due to lifestyle changes and many develop diseases related to reproductive health which favors the growth of this market in developed countries across the globe. Risk of developing serious disorders, if the disease remains untreated, would increase in demand of treatment in hospitals.Global market of Dysmenorrhea Treatment is expected to reach US$ 8.40 billion in 2023 from US$ 5.68 billion in 2016 with a CAGR of approximately 12.28% during the forecast period 2017-2023. Regional Analysis of Dysmenorrhea Treatment Market: Globally, Dysmenorrhea Treatment market is spread across four regions America, Europe, AsiaPacific and Middle East and Africa. North America is the largest market for dysmenorrhea. The factor contributing for the growth of this market is an increase in problems with reproductive healthy among women and changing lifestyle. Asia Pacific is expected to be the fastest growing market for dysmenorrhea treatment. India is expected to be the emerging and fastest growing region. The market shows steady growth in Middle East and Africa. Key Players for Dysmenorrhea Treatment Market: Some of the key players in this market are: Novartis AG (Switzerland), Merck, Inc. (U.S), Bayer Schering Pharma AG (Germany), Abbott Healthcare(U.S), Pfizer, Inc.(U.S). Other players include F. Hoffmann-La Roche Ltd (U.S), Sanofi (U.S), Taj Pharmaceuticals, Ltd (India).

GET SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/727 Segmentation: Global Dysmenorrhea Treatment market has been segmented on the basis of Type which includes Primary Dysmenorrhea and Secondary Dysmenorrhea. Secondary Dysmenorrhea has subsegments namely Endometriosis, Adenomyosis, Uterine myomas, Endometrial polyps, Cervical stenosis, Obstructive malformations of genital tract. On the basis of treatment the market is segmented into non-steroidal anti-inflammatory drugs (NSAIDs), hormonal, and combined oral


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.